Wednesday, January 19, 2022 10:01:31 AM
It's just business, nothing personal. Pumping up the share price by tweeting doesn't profit Acropolis so they are not wasting their time doing that.
They just need to keep the judge happy enough to let them keep Custodianship until they can dump one or more of these tickers and make money on their convertible note(s).
It's a simple formula. If they dump KAST and abandon KATX and LLBO they will make enough money on that convertible note to net a nice profit. If they can also dump KATX and/or LLBO, then great, but they have not spent much money on any of these tickers and won't lose much if KATX anbd LLBO just dissolve into dust.
Even if they DON'T dump KAST they can still make a lot of money on that convertible note. There's no law to stop them from converting, dumping, converting, dumping, throw in a R/S if needed... They can do the same with KATX now, assuming they have a convertible note in KATX that's similar to the KAST note.
As for being worried about LLBO getting Pink Current.... eventually it will probably get to Pink Current. I wouldn't use the word "worried." I'd use the word "suspicious" because Acropolis somehow botched their KAST deal, and if it's true they had reverse-merger candidates identified and lined up in June, then what is the delay with KAST and KATX now?
The only Caren Currier success story I know of is ILUS and that was a very different story.... Acropolis was not a Custodian of ILUS (Currier was a consultant and Acropolis' name does not appear in the financial statements), ILUS had assets (it was never an empty abandoned shell), and that merger happened while ILUS was not Pink Current (it became Pink Current after the merger).
Still... the bottom line is that LLBO was worthless before Acropolis came along because Holmes had already abandoned LLBO and Cyrcadia is dead. Acropolis gave LLBO its only chance.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM